-
1
-
-
0031029379
-
Podocyte loss and progressive glomerular injury in type II diabetes
-
Pagtalunan ME, Miller PL, Jumping-Eagle S, et al, 1997 Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 99: 342-348. (Pubitemid 27053474)
-
(1997)
Journal of Clinical Investigation
, vol.99
, Issue.2
, pp. 342-348
-
-
Pagtalunan, M.E.1
Miller, P.L.2
Jumping-Eagle, S.3
Nelson, R.G.4
Myers, B.D.5
Rennke, H.G.6
Coplon, N.S.7
Sun, L.8
Meyer, T.W.9
-
2
-
-
0035987039
-
Impaired vascular reactivity is present despite normal levels of von Willebrand factor in patients with uncomplicated Type 2 diabetes
-
DOI 10.1046/j.1464-5491.2002.00715.x
-
Ihlemann N, Stokholm KH, Eskildsen PC, 2002 Impaired vascular reactivity is present despite normal levels of von Willebrand factor in patients with uncomplicated Type 2 diabetes. Diabet Med 19: 476-481. (Pubitemid 34639158)
-
(2002)
Diabetic Medicine
, vol.19
, Issue.6
, pp. 476-481
-
-
Ihlemann, N.1
Stokholm, K.H.2
Eskildsen, P.C.3
-
3
-
-
27744432242
-
The immunopharmacological properties of transforming growth factor beta
-
DOI 10.1016/j.intimp.2005.07.006, PII S1567576905002079
-
Le Y, Yu X, Ruan L, et al, 2005 The immunopharmacological properties of transforming growth factor beta. Int Immunopharmacol 5: 1771-1782. (Pubitemid 41586218)
-
(2005)
International Immunopharmacology
, vol.5
, Issue.13-14
, pp. 1771-1782
-
-
Le, Y.1
Yu, X.2
Ruan, L.3
Wang, O.4
Qi, D.5
Zhu, J.6
Lu, X.7
Kong, Y.8
Cai, K.9
Pang, S.10
Shi, X.11
Wang, J.M.12
-
4
-
-
1542313954
-
Transforming growth factor beta and atherosclerosis: So far, so good for the protective cytokine hypothesis
-
Grainger DJ, 2004 Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis. Arterioscler Thromb Vasc Biol 24: 399-404.
-
(2004)
Arterioscler Thromb Vasc Biol
, vol.24
, pp. 399-404
-
-
Grainger, D.J.1
-
5
-
-
33746330410
-
Insulin resistance, hyperin-sulinemia, and renal injury: Mechanisms and implications
-
Sarafidis PA, Ruilope LM, 2006 Insulin resistance, hyperin-sulinemia, and renal injury: mechanisms and implications. Am J Nephrol 26: 232-244.
-
(2006)
Am J Nephrol
, vol.26
, pp. 232-244
-
-
Sarafidis, P.A.1
Ruilope, L.M.2
-
6
-
-
0029761527
-
Insulin and angiotensin II are additive in stimulating TGF-β1 and matrix mRNAs in mesangial cells
-
Anderson PW, Zhang XY, Tian J, et al, 1996 Insulin and angiotensin II are additive in stimulating TGF-beta 1 and matrix mRNAs in mesangial cells. Kidney Int 50: 745-753. (Pubitemid 26302661)
-
(1996)
Kidney International
, vol.50
, Issue.3
, pp. 745-753
-
-
Anderson, P.W.1
Zhang, X.Y.2
Tian, J.3
Correale, J.D.4
Xi, X.P.5
Yang, D.6
Graf, K.7
Law, R.E.8
Hsueh, W.A.9
-
7
-
-
0035153391
-
Translational regulation of renal proximal tubular epithelial cell transforming growth factor-β1 generation by insulin
-
Morrisey K, Evans RA, Wakefield L, Phillips AO, 2001 Translational regulation of renal proximal tubular epithelial cell transforming growth factor-beta1 generation by insulin. Am J Pathol 159: 1905-1915. (Pubitemid 33062532)
-
(2001)
American Journal of Pathology
, vol.159
, Issue.5
, pp. 1905-1915
-
-
Morrisey, K.1
Evans, R.A.2
Wakefield, L.3
Phillips, A.O.4
-
8
-
-
0348226831
-
Diabetic Nephropathy and Transforming Growth Factor-β: Transforming Our View of Glomerulosclerosis and Fibrosis Build-Up
-
Chen S, Jim B, Ziyadeh FN, 2003 Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up. Semin Nephrol 23: 532-543. (Pubitemid 38030087)
-
(2003)
Seminars in Nephrology
, vol.23
, Issue.6
, pp. 532-543
-
-
Chen, S.1
Jim, B.2
Ziyadeh, F.N.3
-
9
-
-
33646794060
-
Essential role of Smad3 in angiotensin II-induced vascular fibrosis
-
DOI 10.1161/01.RES.0000218782.52610.dc, PII 0000301220060428000010
-
Wang W, Huang XR, Canlas E, et al, 2006 Essential role of Smad3 in angiotensin II-induced vascular fibrosis. Circ Res 98: 1032-1039. (Pubitemid 43755224)
-
(2006)
Circulation Research
, vol.98
, Issue.8
, pp. 1032-1039
-
-
Wang, W.1
Huang, X.R.2
Canlas, E.3
Oka, K.4
Truong, L.D.5
Deng, C.6
Bhowmick, N.A.7
Ju, W.8
Bottinger, E.P.9
Lan, H.Y.10
-
10
-
-
0033536016
-
Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development
-
Bobik A, Agrotis A, Kanellakis P, et al, 1999 Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development. Circulation 99: 2883-2891.
-
(1999)
Circulation
, vol.99
, pp. 2883-2891
-
-
Bobik, A.1
Agrotis, A.2
Kanellakis, P.3
-
11
-
-
18144451494
-
Beneficial effects of metformin on haemostasis and vascular function in man
-
Grant PJ, 2003 Beneficial effects of metformin on haemostasis and vascular function in man. Diabetes Metab 29: 6S44-52.
-
(2003)
Diabetes Metab
, vol.29
-
-
Grant, P.J.1
-
12
-
-
3543065104
-
Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: The BIGPRO1 study
-
DOI 10.2337/diacare.21.11.1967
-
Charles MA, Morange P, Eschwege E, Andre P, Vague P, Juhan-Vague I, 1998 Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity. Diabetes Care 21: 1967-1972. (Pubitemid 28478302)
-
(1998)
Diabetes Care
, vol.21
, Issue.11
, pp. 1967-1972
-
-
Aline Charles, M.1
Morange, P.2
Eschwege, E.3
Andre, P.4
Vague, P.5
Juhan-Vague, I.6
-
13
-
-
0242686414
-
Effect of combination glipizide GITS/metformin on fibrinolytic and metabolic parameters in poorly controlled type 2 diabetic subjects
-
Cefalu WT, Schneider DJ, Carlson HE, et al, 2002 Effect of combination glipizide GITS/metformin on fibrinolytic and metabolic parameters in poorly controlled type 2 diabetic subjects. Diabetes Care 25: 2123-2128.
-
(2002)
Diabetes Care
, vol.25
, pp. 2123-2128
-
-
Cefalu, W.T.1
Schneider, D.J.2
Carlson, H.E.3
-
14
-
-
2442745971
-
Effects of metformin on fibrinogen levels in obese patients with type 2 diabetes
-
Fanghanel G, Silva U, Sanchez-Reyes L, Sisson D, Sotres D, Torres EM, 1998 Effects of metformin on fibrinogen levels in obese patients with type 2 diabetes. Rev Invest Clin 50: 389-394. (Pubitemid 29048393)
-
(1998)
Revista de Investigacion Clinica
, vol.50
, Issue.5
, pp. 389-394
-
-
Fanghanel, G.1
Silva, U.2
Sanchez-Reyes, L.3
Sisson, D.4
Sotres, D.5
Torres, E.M.6
-
15
-
-
0035203432
-
Improved endothelial function with metformin in type 2 diabetes [1] (multiple letters)
-
PII S0735109701016308
-
Mather KJ, Verma S, Anderson TJ, 2001 Improved endothelial function with metformin in type 2 diabetes mellitus. J Am Coll Cardiol 37: 1344-1350. (Pubitemid 33116593)
-
(2001)
Journal of the American College of Cardiology
, vol.38
, Issue.7
, pp. 2131-2132
-
-
Mather, K.1
Verma, S.2
Anderson, T.3
-
16
-
-
4043162976
-
The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: A placebo-controlled, randomized clinical trial
-
DOI 10.1210/jc.2004-0019
-
Caballero AE, Delgado A, Aguilar-Salinas CA, et al, 2004 The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: a placebo-controlled, randomized clinical trial. J Clin Endocrinol Metab 89: 3943-3948. (Pubitemid 39071497)
-
(2004)
Journal of Clinical Endocrinology and Metabolism
, vol.89
, Issue.8
, pp. 3943-3948
-
-
Caballero, A.E.1
Delgado, A.2
Aguilar-Salinas, C.A.3
Herrera, A.N.4
Castillo, J.L.5
Cabrera, T.6
Gomez-Perez, F.J.7
Rull, J.A.8
-
17
-
-
0037031267
-
Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus
-
DOI 10.1161/01.CIR.0000025403.20953.23
-
Haffner SM, Greenberg AS, Weston WM, Chen H, Williams K, Freed MI, 2002 Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. Circulation 106: 679-684. (Pubitemid 34851926)
-
(2002)
Circulation
, vol.106
, Issue.6
, pp. 679-684
-
-
Haffner, S.M.1
Greenberg, A.S.2
Weston, W.M.3
Chen, H.4
Williams, K.5
Freed, M.I.6
-
18
-
-
0842289940
-
In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control
-
Pistrosch F, Passauer J, Fischer S, Fuecker K, Hanefeld M, Gross P, 2004 In type 2 diabetes, rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control. Diabetes Care 27: 484-490.
-
(2004)
Diabetes Care
, vol.27
, pp. 484-490
-
-
Pistrosch, F.1
Passauer, J.2
Fischer, S.3
Fuecker, K.4
Hanefeld, M.5
Gross, P.6
-
19
-
-
0037258604
-
Rosiglitazone reduces urinary albumin excretion in type II diabetes
-
DOI 10.1038/sj.jhh.1001444
-
Bakris G, Viberti G, Weston WM, Heise M, Porter LE, Freed MI, 2003 Rosiglitazone reduces urinary albumin excretion in type II diabetes. J Hum Hypertens 17: 7-12. (Pubitemid 36163426)
-
(2003)
Journal of Human Hypertension
, vol.17
, Issue.1
, pp. 7-12
-
-
Bakris, G.1
Viberti, G.2
Weston, W.M.3
Heise, M.4
Porter, L.E.5
Freed, M.I.6
-
20
-
-
0033853610
-
1, and BMI are closely associated in human adipose tissue during morbid obesity
-
Alessi MC, Bastelica D, Morange P, et al, 2000 Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. Diabetes 49: 1374-1380. (Pubitemid 30624239)
-
(2000)
Diabetes
, vol.49
, Issue.8
, pp. 1374-1380
-
-
Alessi, M.-C.1
Bastelica, D.2
Morange, P.3
Berthet, B.4
Leduc, I.5
Verdier, M.6
Geel, O.7
Juhan-Vague, I.8
-
21
-
-
0034604110
-
Role of transforming growth factor β in human disease
-
DOI 10.1056/NEJM200005043421807
-
Blobe GC, Schiemann WP, Lodish HF, 2000 Role of transforming growth factor beta in human disease. N Engl J Med 342: 1350-1358. (Pubitemid 30408720)
-
(2000)
New England Journal of Medicine
, vol.342
, Issue.18
, pp. 1350-1358
-
-
Blobe, G.C.1
Schiemann, W.P.2
Lodish, H.F.3
-
22
-
-
0033195998
-
Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response
-
Ashcroft GS, Yang X, Glick AB, et al, 1999 Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1: 260-266. (Pubitemid 129495775)
-
(1999)
Nature Cell Biology
, vol.1
, Issue.5
, pp. 260-266
-
-
Ashcroft, G.S.1
Yang, X.2
Glick, A.B.3
Weinstein, M.4
Letterio, J.J.5
Mizel, D.E.6
Anzano, M.7
Greenwell-Wild, T.8
Wahl, S.M.9
Deng, C.10
Roberts, A.B.11
-
23
-
-
0033855202
-
Growth factors, cytokines, and renal fibrosis during the course of diabetic nephropathy
-
Rossert J, Terraz-Durasnel C, Brideau G, 2000 Growth factors, cytokines, and renal fibrosis during the course of diabetic nephropathy. Diabetes Metab 26: 16-24. (Pubitemid 30618352)
-
(2000)
Diabetes and Metabolism
, vol.26
, Issue.SUPPL. 4
, pp. 16-24
-
-
Rossert, J.1
Terraz-Durasnel, C.2
Brideau, G.3
-
24
-
-
33947127546
-
Transforming growth factor-beta 1 levels in women with prior history of gestational diabetes mellitus
-
DOI 10.1016/j.diabres.2006.08.014, PII S0168822706003822
-
Yener S, Demir T, Akinci B, et al, 2007 Transforming growth factor-beta 1 levels in women with prior history of gestational diabetes mellitus. Diabetes Res Clin Pract 76: 193-198. (Pubitemid 46400123)
-
(2007)
Diabetes Research and Clinical Practice
, vol.76
, Issue.2
, pp. 193-198
-
-
Yener, S.1
Demir, T.2
Akinci, B.3
Bayraktar, F.4
Kebapcilar, L.5
Ozcan, M.A.6
Biberoglu, S.7
Yesil, S.8
-
25
-
-
16844362676
-
Inflammatory, atherothrombotic aspects of type 2 diabetes
-
Grant PJ, 2005 Inflammatory, atherothrombotic aspects of type 2 diabetes. Curr Med Res Opin 21: S5-12.
-
(2005)
Curr Med Res Opin
, vol.21
-
-
Grant, P.J.1
-
27
-
-
0031944290
-
Regulation of immune responses by TGF-beta
-
Letterio JJ, Roberts AB, 1998 Regulation of immune responses by TGF-beta. Annu Rev Immunol 16: 137-161.
-
(1998)
Annu Rev Immunol
, vol.16
, pp. 137-161
-
-
Letterio, J.J.1
Roberts, A.B.2
-
28
-
-
0027200944
-
Transforming growth factor-β suppresses activation and proliferation of microglia in vitro
-
Suzumura A, Sawada M, Yamamoto H, Marunouchi T, 1993 Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro. J Immunol 151: 2150-2158. (Pubitemid 23235688)
-
(1993)
Journal of Immunology
, vol.151
, Issue.4
, pp. 2150-2158
-
-
Suzumura, A.1
Sawada, M.2
Yamamoto, H.3
Marunouchi, T.4
-
29
-
-
0032916924
-
Increased expression of matrix metalloproteinase-2 in the thickened intima of aged rats
-
Li Z, Froehlich J, Galis ZS, Lakatta EG, 1999 Increased expression of matrix metalloproteinase-2 in the thickened intima of aged rats. Hypertension 33: 116-123. (Pubitemid 29061851)
-
(1999)
Hypertension
, vol.33
, Issue.1 I
, pp. 116-123
-
-
Li, Z.1
Froehlich, J.2
Galis, Z.S.3
Lakatta, E.G.4
-
30
-
-
0037469206
-
Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises. Part III: Cellular and molecular clues to heart and arterial aging
-
DOI 10.1161/01.CIR.0000048894.99865.02
-
Lakatta EG, 2003 Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation 107: 490-497. (Pubitemid 36158054)
-
(2003)
Circulation
, vol.107
, Issue.3
, pp. 490-497
-
-
Lakatta, E.G.1
-
31
-
-
0036235417
-
Altered regulation of matrix metalloproteinase-2 in aortic remodeling during aging
-
DOI 10.1161/01.HYP.0000014506.13322.66
-
Wang M, Lakatta EG, 2002 Altered regulation of matrix metalloproteinase-2 in aortic remodeling during aging. Hypertension 39: 865-873. (Pubitemid 34437541)
-
(2002)
Hypertension
, vol.39
, Issue.4
, pp. 865-873
-
-
Wang, M.1
Lakatta, E.G.2
-
32
-
-
27544463037
-
Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats
-
Wang M, Zhang J, Spinetti G, et al, 2005 Angiotensin II activates matrix metalloproteinase type II and mimics age-associated carotid arterial remodeling in young rats. Am J Pathol 167: 1429-1442. (Pubitemid 41541428)
-
(2005)
American Journal of Pathology
, vol.167
, Issue.5
, pp. 1429-1442
-
-
Wang, M.1
Zhang, J.2
Spinetti, G.3
Jiang, L.-Q.4
Monticone, R.5
Zhao, D.6
Cheng, L.7
Krawczyk, M.8
Talan, M.9
Pintus, G.10
Lakatta, E.G.11
-
33
-
-
33745621423
-
Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin
-
DOI 10.1093/humrep/del003
-
Diamanti-Kandarakis E, Paterakis T, Alexandraki K, et al, 2006 Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin. Hum Reprod 21: 1426-1431. (Pubitemid 44445017)
-
(2006)
Human Reproduction
, vol.21
, Issue.6
, pp. 1426-1431
-
-
Diamanti-Kandarakis, E.1
Paterakis, T.2
Alexandraki, K.3
Piperi, C.4
Aessopos, A.5
Katsikis, I.6
Katsilambros, N.7
Kreatsas, G.8
Panidis, D.9
|